XSJ110
XSJ110 is a potent irreversible topoisomerase I (Topo I) inhibitor with an IC50 value of 0.133 μM. XSJ110 blocks DNA topoisomerization, induces DNA double-strand breaks, and triggers cell cycle arrest at G0/G1 phase, inducing tumor cell apoptosis. XSJ110 is promising for research of ampullary carcinoma (AC) [1].
Product Specifications
CAS Number
203923-65-3
UNSPSC
12352005
Target
Apoptosis; Topoisomerase
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
CCC(C1=C2C(C(N3C2)=CC([C@@](O)(CC)C(OC4)=O)=C4C3=O)=NC5=CC=CC=C51)=O
Molecular Formula
C23H20N2O5
Molecular Weight
404.42
References & Citations
[1]Du L, et al. Antitumor activity of topoisomerase I targeted by camptothecin 7-propionyl derivatives against ampullary carcinoma. Bioorg Chem. 2025 Jul 15;162:108610.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Topo I
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2160-500 1x 500 µL
CD86 (Dendritic Cells Maturation Marker) (C86/2160R), 0.2mg/mL
Sign In for Pricing
View Details 
BNC680793-100 1x 100 µL
Phosphotyrosine (PY793), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
